United States
Search    
Include All CSL Behring Country Sites

Events and Activities

2011 Junior National Championship Sponsored by CSL Behring

JNC Event Information

Celebrating 10 Years: the Junior National Championship!

Developed by CSL Behring, The Gettin’ in the GameSM Junior National Championship (JNC) was the first national golf and baseball competition designed specifically for the bleeding disorders community. The program which celebrates a decade of service this year–features a series of one-day athletic competitions that give children with bleeding disorders an opportunity to compete in appropriate sports like golf and baseball.

  • The JNC features accomplished Gettin’ in the Game (GIG) athletes, who themselves have been diagnosed with bleeding disorders such as hemophilia and von Willebrand disease. These athletes help educate kids and their families about the fundamentals of their respective sports, and provide guidance and support to encourage participants to remain active while managing their condition.

  • Since the first JNC in 2002, CSL Behring has brought the competition to more than 30 towns across the US and has helped nearly 1,000 competitors and their families connect with other members of the bleeding disorders community.

  • The JNC encourages kids with bleeding disorders, such as hemophilia and von Willebrand Disease, to stay physically active to keep their muscles healthy and joints strong–and to regularly connect with their treatment provider to effectively manage their condition.

With the JNC, CSL Behring does more than host a championship tournament: we nurture a community. In the spirit of that collaboration, the program fosters genuine connections as children with bleeding disorders and their families meet and share experiences.

Interested in attending future JNCs?


The commitment behind the community

CSL Behring is committed to connecting people with bleeding disorders to other members of the community who share their experiences. This commitment is demonstrated by our development and maintenance of innovative, high-quality programs, such as the JNC, but also by the company’s range of therapies used in the treatment of a variety of bleeding disorders, such as hemophilia and von Willebrand disease.